Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-13-025881
Filing Date
2013-05-02
Accepted
2013-05-02 11:51:08
Documents
5
Period of Report
2013-05-02

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v343418_6k.htm 6-K 9360
2 GRAPHIC image_001.jpg GRAPHIC 1950
3 EXHIBIT 1 v343418_ex1.htm EX-1 87063
4 GRAPHIC image_003.jpg GRAPHIC 11224
5 EXHIBIT 2 v343418_ex2.htm EX-2 138256
  Complete submission text file 0001144204-13-025881.txt   254027
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35773 | Film No.: 13806399
SIC: 2834 Pharmaceutical Preparations